NATIONAL NEUROLOGICAL AIDS BANK
国家神经艾滋病银行
基本信息
- 批准号:9901575
- 负责人:
- 金额:$ 119.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-05-10 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeAddressAdverse effectsAgeAgingAliquotAnti-Retroviral AgentsAutopsyBiologicalBlood specimenCentral Nervous System DiseasesCentral Nervous System InfectionsCerebrospinal FluidCollaborationsCommunitiesDataData CollectionData Coordinating CenterDatabasesDiabetes MellitusEnrollmentEquipment and supply inventoriesFormalinFreezingFutureGeographyGoalsHIVHIV InfectionsHIV SeronegativityHIV-1HealthHumanHyperlipidemiaImmuneIndividualInflammationInflammatory ResponseKnowledgeLaboratoriesLifeLiquid substanceLong-Term EffectsLongevityMedicalMental disordersMethodologyNational NeuroAids Tissue ConsortiumNervous system structureNeuraxisNeurocognitive DeficitNeurologicNeuropathogenesisNeuropsychologyParaffin EmbeddingParticipantPathogenicityPatientsPenetrationPeripheralPeripheral Nervous SystemPeripheral Nervous System DiseasesPersonsPopulationProceduresProtocols documentationProviderPublicationsResearchResearch PersonnelResourcesSamplingSiteSlideSourceSpecimenStandardizationTimeTissue DonorsTissue EmbeddingTissue HarvestingTissuesUnited States National Institutes of HealthVascular DiseasesViralViral reservoirWorkantiretroviral therapybiobankclinical practiceclinical research sitecohortcomorbiditydata exchangedata sharingdata standardshigh riskhuman tissueimprovedinterestmembermortality risknervous system disorderneuroAIDSneurotoxicpeerprogramsquality assurancerecruitresearch studyrestorationsample collection
项目摘要
Project Summary/Abstract
Human immunodeficiency virus (HIV) remains a global threat to human health and an important cause of
neurologic and psychiatric disorders, despite advances in longevity due to the use of antiretroviral therapy (ART).
ART suppresses HIV replication and allows for partial immune restoration, but may fail to achieve adequate
penetration of the central nervous system (CNS). Currently, ART does not eliminate latent HIV, does not clear
viral reservoirs, and does not normalize the inflammatory response. Further, some ART may have neurotoxic
effects. For these reasons, HIV-associated disorders of the CNS and peripheral nervous system (PNS) have
persisted and evolved despite the use of ART in the aging HIV+ population.
In order to cure HIV infection of the CNS and to elucidate the pathogenic mechanisms of CNS and
PNS disease in ART-treated patients, as well as to continue ongoing studies of aging and HIV co-
morbid conditions, NeuroAIDS investigators require a continuous and reliable source of well-
characterized human tissues, fluids, and data. These invaluable resources are provided by the
National Neurological AIDS Bank (NNAB), a member of the National NeuroAIDS Tissue Consortium
(NNTC). Over the past 19 years, the NNAB has enrolled 806 participants, and currently follows a
cohort of 171 active participants who have agreed to be tissue donors. Most of our donors have
received serial, pre-mortem medical, neurologic, neuropsychologic and laboratory examinations.
NNAB has also performed 259 tissue harvests of cohort members. Over the past 5 years, the NNAB
has distributed 3,766 frozen tissue specimens, 853 fixed tissue specimens, 23,007 formalin fixed paraffin
embedded tissue slides and 3,065 aliquots of fluids to NNTC-approved, qualified investigators.
The NNTC is a consortium of 4 geographically dispersed clinical sites and a Data Coordinating Center
(DCC). Over the past 5 years, NNTC has collectively fulfilled 123 specimen requests that generated 128
publications. The NNAB actively collaborates with the other NNTC clinical sites and the DCC to develop
and maintain standard study protocols, to transfer data to the DCC, to review investigator requests for
NNTC resources, and to allocate such resources in a fair and timely fashion. The NNTC works with the
DCC to insure we maintain an accurate specimen inventory, and to support the harmonized central NNTC
database. The NNAB looks forward to working with our participants, our colleagues, and our requesters
for another 5 years to expand and develop this priceless and indispensable scientific resource.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELYSE J SINGER其他文献
ELYSE J SINGER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELYSE J SINGER', 18)}}的其他基金
PHASE II, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF HIV COGNITIVE
HIV 认知的 II 期、随机、安慰剂对照研究
- 批准号:
7951569 - 财政年份:2009
- 资助金额:
$ 119.09万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 119.09万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 119.09万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 119.09万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 119.09万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 119.09万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 119.09万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 119.09万 - 项目类别:














{{item.name}}会员




